Cytokinetics director Robert E. Landry sells 1,000 common shares worth $74,660
CYTK•Director share sale disclosed
- Director Robert E. Landry sold 1,000 shares of Cytokinetics common stock on Sept. 11, 2026 at $74.66.
- Landry held 9,184 shares directly following the transaction.
